Telix Pharmaceuticals Limited (TLX) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the U.S. Securities and Exchange Commission (SEC) today (US time) regarding its proposed initial public offering of shares. . (Offering) of its American depositary shares (ADSs), representing the Company’s common shares, in the United States Telix has applied to list the ADSs on the Nasdaq Global Market under the symbol “TLX.”
The number of ordinary shares that will be represented by each ADS, the number of ADSs that will be offered and the price per ADS for the proposed Offering have not yet been determined. The Offering is subject to market conditions and there can be no assurance as to whether or when the Offering may be completed.
Jeffries, Morgan Stanley Truist Securities and William Blair will act as joint book-running managers for the proposed offering.
The proposed Offering will be made only by means of a prospectus in accordance with the United States Securities Act of 1933. Copies of the preliminary prospectus, when available, may be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York. , NY 10022, by phone at (877) 821-7388 or by email: [email protected]; Morgan Stanley & Co (NYSE:). LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email: [email protected]; Truist Securities, Inc., Attention: Prospectus Department, 3333 Peachtree Road NE, 9th Floor, Atlanta, GA 30326, by telephone at (800) 685-4786 or by email at: [email protected]; or William Blair & Company, LLC, Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606; by phone (800) 621-0687; or by email at [email protected]. Australian investors are only entitled to invest in accordance with the prospectus if they are exempt from disclosure (for example, as sophisticated or professional investors) in accordance with Corporations Act 2001 (Kt).
remove ads
.
A registration statement relating to the securities referred to herein has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the effectiveness of the Registration Statement. This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification in in accordance with the securities laws of that jurisdiction.